Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Kulkarni

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
JCO Precision Oncology|December 3, 2024
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon CancerSrilatha Simhadri, Jillian N Carrick, Susan Murphy, et al.
Nature Structural & Molecular Biology|May 11, 2010
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersPeter Bouwman, Amal Aly, Jose M Escandell, et al.
Nature Communications|November 18, 2018
RET rearrangements are actionable alterations in breast cancerBhavna S Paratala, Jon H Chung, Casey B Williams, et al.
The Oncologist|June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ HybridizationSiraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
JCO Precision Oncology|December 3, 2024
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon CancerSrilatha Simhadri, Jillian N Carrick, Susan Murphy, et al.
Nature Structural & Molecular Biology|May 11, 2010
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersPeter Bouwman, Amal Aly, Jose M Escandell, et al.
Nature Communications|November 18, 2018
RET rearrangements are actionable alterations in breast cancerBhavna S Paratala, Jon H Chung, Casey B Williams, et al.
The Oncologist|June 2, 2016
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ HybridizationSiraj M Ali, Thomas Hensing, Alexa B Schrock, et al.
Pageof 7